ImClone Systems Incorporated Shares Plunge After Blow In Patent Dispute

BOSTON (Reuters) - Shares of ImClone Systems Inc. plunged more than 11 percent in pre-market electronic trading on Tuesday after a court invalidated the biotechnology company's ownership of a key cancer drug patent.

>>> Discuss This Story

MORE ON THIS TOPIC